These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Design and synthesis of lipidic organoalkoxysilanes for the self-assembly of liposomal nanohybrid cerasomes with controlled drug release properties. Liang X; Li X; Jing L; Xue P; Jiang L; Ren Q; Dai Z Chemistry; 2013 Nov; 19(47):16113-21. PubMed ID: 24123292 [TBL] [Abstract][Full Text] [Related]
3. Lipoamino acid-based cerasomes for doxorubicin delivery: Preparation and in vitro evaluation. Gileva A; Sarychev G; Kondrya U; Mironova M; Sapach A; Selina O; Budanova U; Burov S; Sebyakin Y; Markvicheva E Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():724-734. PubMed ID: 30948110 [TBL] [Abstract][Full Text] [Related]
4. Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme. Wang L; Wang X; Shen L; Alrobaian M; Panda SK; Almasmoum HA; Ghaith MM; Almaimani RA; Ibrahim IAA; Singh T; Baothman AA; Choudhry H; Beg S Biomed Pharmacother; 2021 Jun; 138():111461. PubMed ID: 33706131 [TBL] [Abstract][Full Text] [Related]
5. Stable cerasomes for simultaneous drug delivery and magnetic resonance imaging. Cao Z; Zhu W; Wang W; Zhang C; Xu M; Liu J; Feng ST; Jiang Q; Xie X Int J Nanomedicine; 2014; 9():5103-16. PubMed ID: 25395848 [TBL] [Abstract][Full Text] [Related]
6. Recent advances in liposomal nanohybrid cerasomes as promising drug nanocarriers. Yue X; Dai Z Adv Colloid Interface Sci; 2014 May; 207():32-42. PubMed ID: 24368133 [TBL] [Abstract][Full Text] [Related]
7. Cerasome Versus Liposome: A Comparative Pharmacokinetic Analysis Following Intravenous Administration into Rats. Bahri S; Abdollahizad E; Mahlooji I; Rezaee E; Abbasian Z; Dadashzadeh S Iran J Pharm Res; 2023; 22(1):e138362. PubMed ID: 38444706 [TBL] [Abstract][Full Text] [Related]
8. Redox responsive liposomal nanohybrid cerasomes for intracellular drug delivery. Zhou G; Li L; Xing J; Jalde S; Li Y; Cai J; Chen J; Liu P; Gu N; Ji M Colloids Surf B Biointerfaces; 2016 Dec; 148():518-525. PubMed ID: 27690240 [TBL] [Abstract][Full Text] [Related]
9. Modulation of release of paclitaxel from composite cerasomes. Cao Z; Yue X; Jin Y; Wu X; Dai Z Colloids Surf B Biointerfaces; 2012 Oct; 98():97-104. PubMed ID: 22659210 [TBL] [Abstract][Full Text] [Related]
10. Overcoming drug-resistant lung cancer by paclitaxel-loaded hyaluronic acid-coated liposomes targeted to mitochondria. Tian Y; Zhang H; Qin Y; Li D; Liu Y; Wang H; Gan L Drug Dev Ind Pharm; 2018 Dec; 44(12):2071-2082. PubMed ID: 30112929 [TBL] [Abstract][Full Text] [Related]
16. Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation. Jiang K; Shen M; Xu W Int J Nanomedicine; 2018; 13():2561-2569. PubMed ID: 29731631 [TBL] [Abstract][Full Text] [Related]
17. Dual-targeting for brain-specific liposomes drug delivery system: Synthesis and preliminary evaluation. Peng Y; Zhao Y; Chen Y; Yang Z; Zhang L; Xiao W; Yang J; Guo L; Wu Y Bioorg Med Chem; 2018 Sep; 26(16):4677-4686. PubMed ID: 30098913 [TBL] [Abstract][Full Text] [Related]
18. Stabilized liposomal nanohybrid cerasomes for drug delivery applications. Cao Z; Ma Y; Yue X; Li S; Dai Z; Kikuchi J Chem Commun (Camb); 2010 Aug; 46(29):5265-7. PubMed ID: 20411203 [TBL] [Abstract][Full Text] [Related]
19. Novel drug delivery liposomes targeted with a fully human anti-VEGF165 monoclonal antibody show superior antitumor efficacy in vivo. Shi C; Cao H; He W; Gao F; Liu Y; Yin L Biomed Pharmacother; 2015 Jul; 73():48-57. PubMed ID: 26211582 [TBL] [Abstract][Full Text] [Related]
20. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art. Karim R; Palazzo C; Evrard B; Piel G J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]